Stuart A. Arbuckle
2017
In 2017, Stuart A. Arbuckle earned a total compensation of $4.4M as EVP & Chief Commercial Officer at Vertex Pharmaceuticals, a 21% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $699,300 |
|---|---|
| Option Awards | $888,210 |
| Salary | $700,000 |
| Stock Awards | $2,100,013 |
| Other | $13,110 |
| Total | $4,400,633 |
Arbuckle received $2.1M in stock awards, accounting for 48% of the total pay in 2017.
Arbuckle also received $699.3K in non-equity incentive plan, $888.2K in option awards, $700K in salary and $13.1K in other compensation.
Rankings
In 2017, Stuart A. Arbuckle's compensation ranked 2,269th out of 14,666 executives tracked by ExecPay. In other words, Arbuckle earned more than 84.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,269 out of 14,666 | 85th |
Division Manufacturing | 790 out of 5,772 | 86th |
Major group Chemicals And Allied Products | 212 out of 2,075 | 90th |
Industry group Drugs | 161 out of 1,731 | 91st |
Industry Pharmaceutical Preparations | 126 out of 1,333 | 91st |
Source: SEC filing on April 26, 2019.
Arbuckle's colleagues
We found six more compensation records of executives who worked with Stuart A. Arbuckle at Vertex Pharmaceuticals in 2017.
2017
Jeffrey Leiden
Vertex Pharmaceuticals
Chief Executive Officer
2017
Michael Parini
Vertex Pharmaceuticals
EVP & Chief Legal and Administrative Officer
2017
Ian Smith
Vertex Pharmaceuticals
Chief Operating Officer
2017
David Altshuler
Vertex Pharmaceuticals
Chief Scientific Officer
2017
Amit Sachdev
Vertex Pharmaceuticals
EVP & Chief Regulatory Officer
2017
Thomas Graney
Vertex Pharmaceuticals